greeksoup/ stock research

Merck (MRK) FY2009 results: revenue $27.4 billion, up 15.0% on the year

Merck & Co., Inc. (MRK) reported revenue of $27.4 billion for fiscal 2009, the year ended 31 December 2009, up 15.0% on the year before. Net income was $12.9 billion, up 65.2%, and diluted earnings per share $5.65. The figures are the company's own, from the 10-K it filed with the SEC on 1 March 2010.

Revenue
$27.4 billion
+15.0% on the year
FY2007FY2009
Operating margin
n/a
FY2007FY2009
Net income
$12.9 billion
+65.2% on the year
FY2007FY2009
Diluted EPS
$5.65
+55.6% on the year
FY2007FY2009

this yearthe year beforeHover a bar for its figure.

The year in brief

Income statement (profit and loss)

$ millionFY2009FY2008FY2007On the yearLast 8 years
Revenue27,42823,85024,198+15.0%
Cost of revenue9,0195,5826,141+61.6%
Gross profit18,40918,26818,057+0.8%
Gross margin67.1%76.6%74.6%
Research and development5,8454,8054,883+21.6%
Selling, general and administrative8,5437,3777,557+15.8%
Interest expense460251n/a+83.3%
Pre-tax income15,290n/an/a
Income tax2,2681,99995.3+13.4%
Effective tax rate14.8%n/an/a
Net income12,9017,8083,275+65.2%
Net margin47.0%32.7%13.5%
Diluted EPS$5.65$3.63$1.49+55.6%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2009FY2008FY2007On the yearLast 8 years
Operating cash flow3,3926,5726,999-48.4%
Capital expenditure1,4611,2981,011+12.5%
Free cash flow1,9315,2735,988-63.4%
Free cash flow margin7.0%22.1%24.7%
Cash from investing3,156-1,834-2,810
Cash from financing-1,638-5,522-4,866
Depreciation and amortisation2,5761,6311,988+57.9%
Share-based compensation416348330+19.4%
Buybacks0.02,7251,430
Dividends paid3,2153,2783,307-1.9%
Dividend per share$1.52$1.52$1.520.0%
Diluted shares, weighted2,273m2,143mn/a+6.1%

Balance sheet

$ millionFY2009FY2008FY2007On the yearLast 8 years
Shareholders' equity59,05818,75820,591+214.8%
Non-controlling interest2,4272,409n/a+0.8%
Debt17,5003,943n/a+343.8%
Other liabilities33,32922,085n/a+50.9%
Total liabilities and equity112,31447,196n/a+138.0%
Fixed assets18,27412,000n/a+52.3%
Goodwill12,0381,439n/a+736.6%
Intangible assets47,757525n/a+8,989.6%
Investments7257,609n/a-90.5%
Cash and equivalents9,3114,3685,336+113.2%
Receivables6,6032,816n/a+134.5%
Inventory8,0552,091n/a+285.2%
Other assets9,55016,347n/a-41.6%
Total assets112,31447,196n/a+138.0%

10-K for the year ended 31 December 2009, filed 1 March 2010: the filing.